Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Cathy Wurzer

How significant is the latest Alzheimer's research

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

A new insight into how a natural enzyme affects memory-loss in mice is getting a lot of attention for what it might mean for humans with Alzheimer's disease.

World-renowned Alzheimer's researcher Karen Ashe at the University of Minnesota recently published her findings in the journal Nature Medicine.

She found she was able to reverse memory loss in mice by lowering an enzyme called caspase-2.

She'll be partnering with researchers at the Mayo Clinic to work on advancing this discovery. Morning Edition host Cathy Wurzer spoke with Ron Petersen, the director of the Mayo's Alzheimer's Disease Research Center, for more on the subject.

To hear the whole conversation, click the play button above.